Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.

doi:10.1007/s00439-006-0212-3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.

Human genetics - 1 Sept 2006

Wang Sophia S, Cozen Wendy, Severson Richard K, Hartge Patricia, Cerhan James R, Davis Scott, Welch Robert, Rothman Nathaniel, Chanock Stephen J

Abstract excerpt

To investigate the role of cell cycle gene variations in lymphomagenesis, we evaluated associations (odds ratios [OR] and 95% confidence intervals [CI]) in polymorphisms from seven candidate genes in 1,172 non-Hodgkin lymphoma (NHL) cases and 982 population-based controls. The cyclin D1 (CCND1) splice variant G870A (rs603965) increased NHL risk (OR(AA) = 1.4, 95% CI = 1.1-1.8, P-trend = 0.021), which was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alternative Splicing

Share to Case-Control Studies

Share to CCND1 gene

Share to Genetic Predisposition to Disease

Share to Lymphoma, Non-Hodgkin

Share to Odds Ratio

Share to Risk Factors

Source

Open in PubMed

Identifiers

PMID: 16783567
DOI: 10.1007/s00439-006-0212-3

Genes

CCND1

Variants

rs603965

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.PMID 16783567Read ↗

Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.Semantic proximity Read ↗

The CCND1 G870A gene polymorphism and leukemia or non-Hodgkin lymphoma risk: a meta-analysis.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.Semantic proximity Read ↗

Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation.Semantic proximity Read ↗

Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.Semantic proximity Read ↗

Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.Semantic proximity Read ↗

Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.Semantic proximity Read ↗

NKG2D genetic variants and cancer susceptibility: Integrating case-control evidence with meta-analysis.Semantic proximity Read ↗

CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Genetic variation in cell death genes and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.Semantic proximity Read ↗

CCND1 Splice Variant as A Novel Diagnostic and Predictive Biomarker for Thyroid CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.